<DOC>
	<DOCNO>NCT01225991</DOCNO>
	<brief_summary>The purpose study examine effect milnacipran treatment pain rheumatoid arthritis old adult .</brief_summary>
	<brief_title>Milnacipran Treatment Pain Older Adults With Rheumatoid Arthritis</brief_title>
	<detailed_description>This 12-week open-label trial milnacipran treatment pain rheumatoid arthritis old adult . The investigator interested relationship chronic pain inflammation , resilience , fatigue , physical mental functioning . The investigator anticipate effective pain reduction result improve fatigue , resilience , physical mental functioning reduce level inflammation . The investigator seek examine directly 30 old adult ( 55 year age old ) rheumatoid arthritis use milnacipran treatment pain absence clinical major depression . This propose trial serve pilot study estimate effect drug pain functional outcome , well aid dose-finding population .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Diagnosis . RA subject evaluate board certify rheumatologist use revise criterion establish American College Rheumatology ( ACR ) . This require least four follow seven criterion : 1 ) morning joint stiffness ; 2 ) arthritis 3 joint area ; 3 ) arthritis hand joint ; 4 ) symmetric arthritis ; 5 ) rheumatoid nodule ; 6 ) presence serum rheumatoid factor 7 ) change posteroanterior hand wrist radiograph . In addition , criterion 14 must present least four week . Individuals diagnose juvenile RA exclude . Medication Use RA patient . RA subject take disease modify antirheumatic drug ( DMARDs ) must stable regime one month study stable throughout study . RA subject use DMARDs categorized follow : 1 ) DMARDs ; 2 ) DMARD monotherapy sulfasalazine , hydroxychloroquine , minocycline , azothioprine , 3 ) DMARD monotherapy methotrexate leflunomide , 4 ) biologic therapy without concomitant DMARDs . Medical condition . Subjects eligible study base follow criterion : ( 1 ) presence acute uncontrolled comorbid medical condition limit include cardiovascular ( e.g. , history acute coronary event , stroke , uncontrolled HTN ) neurological disease ( e.g. , Parkinson 's disease ) , well pain disorder ; ( 2 ) presence comorbid inflammatory disorder Crohn 's disease ulcerative colitis autoimmune disorder ; ( 3 ) presence uncontrolled medical condition deem investigator interfere propose study procedure , put study participant undue risk ; ( 4 ) presence chronic infection ( e.g . positive purified protein derivative ( PPD ) test ) ) due contraindication tumor necrosis factor ( TNF ) antagonist use individual also chronic infection produce elevation proinflammatory cytokine ; ( 5 ) presence acute infectious illness two week prior experimental session ; ( 6 ) pregnancy breastfeed effect neuroendocrine system sleep ; ( 7 ) woman , presence vasomotor symptom due effect symptoms measure sleep ; ( 8 ) use hormone contain medication include steroid ; ( 9 ) current and/or regular use nonsteroidal antiinflammatory drug ( NSAID ) medication . Psychiatric Disorders . RA subject current lifetime history major Depressive Disorder Diagnostic Statistical Manual Mental Disorders IV ( DSMIV ) psychiatric disorder ( e.g . substance dependence ) exclude due know effect major depression pain . Although depressive symptom occur many 40 % RA patient , prevalence syndromal major depressive disorder considerably less , anticipate exclusion current lifetime history major depressive disorder substantially alter subject flow . More 75 % select sample RA subject University California , Los Angeles ( UCLA ) affiliate clinic history comorbid psychiatric disorder . Medication use . Subjects use follow medication past two month exclude study : ( 1 ) previous use Nitrogen Mustard , Cyclosporin , Cytotoxin , Cyclophosphamide ; ( 2 ) regular use analgesic opioids , ( 3 ) regular use prednisone &gt; 10mg prednisone , ( 4 ) psychotropic medication , include selective serotonergic reuptake inhibitor , antidepressant , anxiolytic , hypnotic , sedative barbiturate . We also exclude current smoker know effect tobacco use proinflammatory cytokine level . ( Helen , I would suggest remove sentence . It clear study patient high risk susceptibility increase disease activity smoking . It may decrease enrollment . )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Pain , Fatigue , Geriatric , Rheumatoid Arthritis , Milnacipran</keyword>
</DOC>